| Disitamab Vedotin investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 29show all (up to 200) |
|---|
| → investigated in trials for | Malignant Breast Neoplasm 10 trials (9 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Breast Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Gastric Neoplasm 8 trials (5 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Gastric Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Breast Neoplasmcancer_family 5 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Breast Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gastroesophageal Junction Adenocarcinoma 4 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Gastroesophageal Junction Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Urothelial Carcinoma 4 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Urothelial Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bladder Neoplasmsubtype 3 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Bladder Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gastric Neoplasmcancer_family 3 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Gastric Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | HER2-Positive Gastric Adenocarcinoma 3 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | HER2-Positive Gastric Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lung Non-Small Cell Carcinoma 3 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Lung Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Bladder Neoplasm 3 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Bladder Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bladder Urothelial Carcinoma 2 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Bladder Urothelial Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Colorectal Neoplasmsubtype 2 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Colorectal Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gastric Carcinoma 2 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Gastric Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Cervical Neoplasm 2 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Cervical Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Renal Pelvis and Ureter Urothelial Carcinoma 2 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Renal Pelvis and Ureter Urothelial Carcinoma | 2 | Observed | clinicaltrials | graph → |